Member Info for Zoom0001

I'm not able to attend the AGM but could somebody possibly high-five Chris Yates's face on my behalf?

Thanks in advance.

Feck me. I didn’t think things could be more negative than the last update but they’ve managed to pull it off and very successfully.

From everything they had in pipeline including six tech transfers it appears we are left with 2 tech transfers. No acknowledgment of Vatic, no mention of the Taiwan deal.

What an absolute, almost fraudulent disgrace. I understand Avacta and Vatic to a degree but everything else appears to have been fabricated hot air.

Yes. They purchased additional shares on the open market. It’s not quite the same.

I would have thought the sell off would happen today so I’m slightly encouraged that the price hasn’t dropped yet, but will probably end up with a large amount of egg over my face at some point.

I guess we will find out if the recent director buys were financially prudent tomorrow.

One deal (not imaginary like Taiwan) is all it will take. Come on Yates, what have you and the other eighty members of staff been doing for the last year and a half? There must be something to share.

The mere fact that they haven’t acknowledged Vatics’s demise pretty much sums up the experience for investors since IPO. I’ve said before, they have the facilities and expertise to land a good contract. They just don’t seem capable. One good contract is all it will take here but just seem to be drip feed bad news.

The Flu collaboration was with Vatic and announced 5 minutes prior to a set of “not so good interims” if my memory serves.

I remain invested but something needs to change and quickly. They’ve had plenty of time and around 28 million of IPO and investor funds to get their ducks in a row. If current management aren’t able to do this, they need to make some changes.

Read back thorough some of their market announcements and compare them with reality. A bit of bad luck combined with appalling decision making and dodgy, inaccurate, almost desperate communications (usually before results).

HMG test wasn’t fit for purpose. HMG contract cancellation withheld from the market in the trading update. Vatic, Avacta, Taiwan, Components deal for a MINIMUM of 2.7 mill, Vatic Flu collaboration, Deepverge, Lymes disease. Where are the contracts?

Bad luck?

The fear comes from complete and utter lack of progress on any front for over a year and a half now.
Yates and Hand must have degrees in corporate Armageddon. You would have to try really hard to **** things up as much as they have since IPO. I’m still holding because I can’t quite believe a company can be managed so badly and they have something in the pipeline that will surprise us all and save the day.

Maybe I’m in denial and it’s confirmation bias.

Why do you constantly share information about your position here? It’s of absolutely no interest to me and I would imagine many others share the same view.

Could be a ramp.

Mona Kamir and Alex Shepherd relinquished their interest in the company a couple of weeks ago. I don’t understand the the implications but somebody here eluded to administration. To me it looks like venture capitalists have taken a large proportion of the company rather than administrators but I’m happy to be corrected.

Close but no cigar.

My feeling is “feck me this is boring”. Come on Abingdon, you have great facilities/capacity, years of experience and hot emerging market. Get something over the line successfully…anything!

What on earth are you on about?

They’re not really giving us anything to feel optimistic about and this has been the case for sometime.

Something has to drop into place soon, but it’s been an absolute car crash so far. One good production deal is all it will take. Surely with Abingdon are capable of such a deal with their years of experience and facilities.

I would have thought a meaningful production contract would be the priority rather than changing the name of the company. Just a thought.

Not really news is it. The business update eluded to Vatic going nowhere.

Nobody’s invested in JB so it’s an inconsequential comment.
Abingdon on the other hand have delivered sweet FA to date. This is the problem and the reason we’re at a paltry 6p per share which is less than a quarter of the placing price, which in turn was quarter of the IPO price. Let that sink in.
Disgraceful and more embarrassing with each day that passes.

Yes thanks Muck. I too enjoy your posts. Always concise and factual.